Sodium-glucose linked transporter 2 (SGLT2) inhibitors are a new class of anti-diabetes mellitus (DM) drugs. SGLT2 is usually involved in the reabsorption of about 90% of the glucose filtered by the glomerular. SGLT2 inhibitors directly reduce blood sugar by inhibiting the active transport of glucose by SGLT2, inhibiting the reabsorption of glucose by the kidneys, increasing urinary glucose excretion. SGLT2 inhibitors are becoming increasingly important in the treatment of type 2 DM (T2DM), as they can not only reduce blood glucose, but also have cardio-renal protective effects. SGLT2 inhibitors have been widely used after being marketed in China. Now, the pharmacokinetic characteristics, hypoglycemic effect, cardiovascular protection, renal protection and adverse reactions of SGLT2 inhibitors that have been listed in China were compared in order to provide reference for clinical medication.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |